Publication date: Sep 13, 2024
Open Access PDF
Concepts | Keywords |
---|---|
Clinicians | Clinicians |
Covid | Covid |
Drugs | Drugs |
Immunocompromised | Guidance |
Helps | |
Immunocompromised | |
Jama | |
Pemivibart | |
Protect |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Immunocompromised Patients |
disease | MESH | COVID-19 |
disease | MESH | leukemia |
disease | MESH | lymphoma |
disease | IDO | cell |
drug | DRUGBANK | Nonoxynol-9 |
disease | MESH | infection |
disease | MESH | complications |
disease | MESH | death |
disease | MESH | Infectious Diseases |
disease | MESH | Emergency |
drug | DRUGBANK | Indoleacetic acid |
disease | MESH | Allergy |
drug | DRUGBANK | Coenzyme M |
pathway | REACTOME | Immune System |
disease | MESH | anaphylaxis |
disease | IDO | susceptibility |
drug | DRUGBANK | Aspartame |
disease | IDO | host |
Original Article
(Visited 2 times, 1 visits today)